09.01.2013 Views

Black Cohosh - Non-Timber Forest Products

Black Cohosh - Non-Timber Forest Products

Black Cohosh - Non-Timber Forest Products

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

National Institutes of Health, National Toxicology Program. 2002. <strong>Black</strong><br />

cohosh. http://ntp.niehs.nih.gov/index.cfm?objectid=07110B8E-B6F8-<br />

602B-BFB961E97D06B225. [Date accessed: January 7, 2004].<br />

Reviews research on black cohosh safety, including the identification and<br />

structure of chemical constituents, exposure information, use patterns,<br />

regulatory status, evidence for carcinogenic activity, biological effects,<br />

health effects of active constituents, and references.<br />

Keywords: Cancer, chemical constituents, physiological actions, regulatory<br />

status, research reviews.<br />

Nesselhut, T.; Bodinet, C.; Schneider, P.; Freudenstein, J., inventors;<br />

Schaper & Bruemmer GmbH & Co., assignee. 2001. Use of extract of<br />

Cimicifuga racemosa. U.S. patent 6,267,994. July 31. 1 p. Int. CI2 A61K<br />

035/78. http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HI<br />

TOFF&p=1&u=/netahtml/search-bool.html&r=1&f=G&l=50&co1=AND<br />

&d=ptxt&s1=6,267,994.WKU.&OS=PN/6,267,994&RS=PN/6,267,994.<br />

[Date accessed: September 13, 2004].<br />

Patents the use of a black cohosh extract to treat estrogen-dependent<br />

tumors. <strong>Black</strong> cohosh has been found to increase the effectiveness of the<br />

anticancer drug tamoxifen, reducing the dosage needed to treat cancer. This<br />

is beneficial both because tamoxifen can be toxic in high doses, and because<br />

black cohosh can reduce hot flashes experienced by breast cancer survivors.<br />

Keywords: Cancer, drug interactions, medicinal uses, patents.<br />

Nesselhut, T.; Borth, S.; Kuhn, W. 1993. Influence of Cimicifuga extracts<br />

with estrogen-like activity on the in vitro proliferation of mamma<br />

carcinoma cells. Archives of Gynecology and Obstetrics. 254: 817-818.<br />

Shows that Remifemin ® , at concentrations of > 2.5 µgm/ml, inhibits the<br />

proliferation of E2 positive breast cancer cells. Inhibition decreased when<br />

Remifemin ® was combined with estradiol, but increased when combined<br />

with tamoxifen, and was greater than for either Remifemin ® or tamoxifen<br />

used alone. The authors suggested that the inhibition of breast cancer cells<br />

was mediated through the estrogen receptor and that the positive effects of<br />

tamoxifen were enhanced by black cohosh.<br />

Keywords: Cancer, clinical studies, drug interactions, Remifemin ® .<br />

60

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!